The EUROpean Treatment & Reduction of Acute Coronary Syndromes cost analysis
The EUROTRACS project’s main objective consists of utility analysis (cost-effectiveness) in terms of cost per Quality-Adjusted Life Years (QALY) in the following fields:
- three interventions designed to prevent coronary artery disease incidence aimed at reducing: smoking, dyslipidemia, hypertension population prevalence;
- optimal use of coronary angiography and percutaneous intervention procedures in the management of patients with acute coronary syndrome.
The proposed action will allow policy makers to design national and international public health actions aimed at decreasing coronary artery disease (CAD) morbidity and mortality in the most cost-efficient manner and it will in turn increase Europeans quality of life and longevity. In addition, obtaining 10-year estimates of CAD mortality and CAD-associated costs will allow a more rational allocation of health resources in European countries.
The EUROTRACS project was funded by the Executive Agency for Health and Consumers entrusted by the European Commission to implement the Health Programme (2008-2013). EUROTRACS contributed to the EU Health Programme main objective “to promote health, including the reduction of health inequalities”.